Evidence map›Paper›PMID 38100428›Full record

ArticlePloS one2023

Using hypergraphs to quantify importance of sets of diseases by healthcare resource utilisation: A retrospective cohort study.

James Rafferty, Alexandra Lee, Ronan A Lyons, Ashley Akbari, Niels Peek, Farideh Jalali-Najafabadi, Thamer Ba Dhafari, Jane Lyons, Alan Watkins, Rowena Bailey

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

James RaffertyPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.ORCID 0000-0002-1667-7265
Alexandra LeePopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Ronan A LyonsPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Ashley AkbariPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.ORCID 0000-0003-0814-0801
Niels PeekDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.
Farideh Jalali-NajafabadiCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
Thamer Ba DhafariDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.
Jane LyonsPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Alan WatkinsPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Rowena BaileyPopulation Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Swansea University · GBManchester Academic Health Science Centre · GB

Funding

Medical Research Council MR/S027750/1
6 · The paper itself

Abstract

Rates of Multimorbidity (also called Multiple Long Term Conditions, MLTC) are increasing in many developed nations. People with multimorbidity experience poorer outcomes and require more healthcare intervention. Grouping of conditions by health service utilisation is poorly researched. The study population consisted of a cohort of people living in Wales, UK aged 20 years or older in 2000 who were followed up until the end of 2017. Multimorbidity clusters by prevalence and healthcare resource use (HRU) were modelled using hypergraphs, mathematical objects relating diseases via links which can connect any number of diseases, thus capturing information about sets of diseases of any size. The cohort included 2,178,938 people. The most prevalent diseases were hypertension (13.3%), diabetes (6.9%), depression (6.7%) and chronic obstructive pulmonary disease (5.9%). The most important sets of diseases when considering prevalence generally contained a small number of diseases, while the most important sets of diseases when considering HRU were sets containing many diseases. The most important set of diseases taking prevalence and HRU into account was diabetes & hypertension and this combined measure of importance featured hypertension most often in the most important sets of diseases. We have used a single approach to find the most important sets of diseases based on co-occurrence and HRU measures, demonstrating the flexibility of the hypergraph approach. Hypertension, the most important single disease, is silent, underdiagnosed and increases the risk of life threatening co-morbidities. Co-occurrence of endocrine and cardiovascular diseases was common in the most important sets. Combining measures of prevalence with HRU provides insights which would be helpful for those planning and delivering services.

Indexed as

Diabetes MellitusHypertensionComorbidityHumansPatient Acceptance of Health CarePrevalenceRetrospective Studies

Identifiers

PMID38100428
PMCPMC10723667
OpenAlexW4389816894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.